HHS cancels funding for Moderna bird flu vaccine
Digest more
Top News
Overview
Impacts
On this week's podcast, STAT's Helen Branswell talks about BARDA cancelling its contract with Moderna and RFK Jr. taking an unprecedented move on Covid shots.
CAMBRIDGE, MA / ACCESS Newswire / May 23, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that it has submitted an application to the U.S. Food and Drug Administration (FDA) for review of its Spikevax 2025-2026 formula,
Moderna has withdrawn the BLA for mRNA-1083, a combination vaccine against seasonal influenza and SARS-CoV-2, after consulting with FDA.
Explore more